The brand name Zepbound (tirzepatide) is now much affordable than compounded Tirzepatide ( at $299/month on the lowest dose of 2.5mg /week and $499/month on the highest doses of 7.5mg and above ), so we recommend our patients to go that route
Two randomized controlled trials demonstrated reduced bone loss during weight loss with GLP-1 RA compared to placebo (51, 52)
If you experience any suspected adverse reactions to supplements, report them through the MHRA Yellow Card scheme, which monitors the safety of medicines and supplements
Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide
Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice